巨子生物胶原蛋白及透明质酸钠复合溶液产品获医疗器械注册证

Core Viewpoint - The company, Juzi Biotechnology, announced that its wholly-owned subsidiary, Shaanxi Juzi Biotechnology Co., Ltd., has received a medical device registration certificate from the National Medical Products Administration of China for a recombinant type I α1 collagen and sodium hyaluronate composite solution product [1] Group 1 - The product is primarily composed of recombinant collagen and sodium hyaluronate [1] - It is intended for injection into the dermis to improve the smoothness of the cheek area [1]